Source:http://linkedlifedata.com/resource/pubmed/id/21320276
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2011-7-28
|
pubmed:abstractText |
Study Type - Prognosis (systematic review). Level of Evidence: 2b. What's known on the subject? and What does the study add? Overtreatment of prostate cancer is a major problem in contemporary urological practice. The Epstein Criteria reduces overtreatment by identifying insignificant prostate cancers that may be amenable to surveillance therapy. This systematic review of the Epstein Criteria validation studies provides a collective insight into the application and accuracy of the Epstein Criteria to predict for insignificant prostate cancer across different institutions and geographies.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1464-410X
|
pubmed:author | |
pubmed:copyrightInfo |
© 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
108
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
518-25
|
pubmed:meshHeading |
pubmed-meshheading:21320276-Humans,
pubmed-meshheading:21320276-Male,
pubmed-meshheading:21320276-Nomograms,
pubmed-meshheading:21320276-Prognosis,
pubmed-meshheading:21320276-Prostate-Specific Antigen,
pubmed-meshheading:21320276-Prostatic Neoplasms,
pubmed-meshheading:21320276-Sensitivity and Specificity,
pubmed-meshheading:21320276-Severity of Illness Index,
pubmed-meshheading:21320276-Tumor Burden
|
pubmed:year |
2011
|
pubmed:articleTitle |
Epstein criteria for insignificant prostate cancer.
|
pubmed:affiliation |
Conway Institute, University College Dublin, Dublin, Ireland. sheng-fei.oon@ucd.ie
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|